These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11460011)

  • 1. Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Ito T; Saito M; Morishita E; Yamazaki M; Suga Y; Miyamoto KI; Nakao S
    Blood Coagul Fibrinolysis; 2001 Jun; 12(4):275-81. PubMed ID: 11460011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Ito T; Saito M; Morishita E; Yamazaki M; Aoshima K; Takami A; Yoshida T; Suga Y; Miyamoto K; Nakao S
    Eur J Haematol; 2001 Sep; 67(3):170-5. PubMed ID: 11737250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serial changes in protein C, antithrombin III, alpha 2-plasmin inhibitor, plasminogen and von Willebrand factor during the course of disseminated intravascular coagulation (DIC)].
    Takahashi H; Hanano M; Takizawa S; Tatewaki W; Fuse I; Satoh K; Wada K; Shibata A
    Rinsho Ketsueki; 1988 Mar; 29(3):336-43. PubMed ID: 3260969
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
    Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
    Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
    Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
    Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
    Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
    Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation.
    Zhang J; Xue M; Chen Y; Liu C; Kuang Z; Mu S; Wei W; Yin J; Xiang H; Hu Y; Long X; Fang S; Sun S; Wang B; Tong C; Song Z
    Ann Palliat Med; 2021 Oct; 10(10):10170-10184. PubMed ID: 34551574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
    Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
    Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.
    Hayakawa M; Sawamura A; Gando S; Jesmin S; Naito S; Ieko M
    Thromb Res; 2012 Dec; 130(6):906-13. PubMed ID: 22353215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
    Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
    Harpel PC
    J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in levels of t-PA and alpha 2PI-plasmin complex in plasma in patients with DIC.
    Matsuda T; Asakura H; Ito K; Saito M; Jokaji Y; Uotani C; Kumabashiri I
    Thromb Res Suppl; 1988; 8():143-51. PubMed ID: 3144764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease.
    Brandtzaeg P; Joø GB; Brusletto B; Kierulf P
    Thromb Res; 1990 Jan; 57(2):271-8. PubMed ID: 2315889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pathological Clarification of Sepsis-Associated Disseminated Intravascular Coagulation Based on Comprehensive Coagulation and Fibrinolysis Function.
    Onishi T; Nogami K; Ishihara T; Inoue S; Kawaguchi M; Nishio K; Fukushima H; Kobayashi H; Amano I; Nishikubo T; Yamasaki M; Kasahara M; Shima M
    Thromb Haemost; 2020 Sep; 120(9):1257-1269. PubMed ID: 32679594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis.
    Ikeda M; Matsumoto H; Ogura H; Hirose T; Shimizu K; Yamamoto K; Maruyama I; Shimazu T
    J Crit Care; 2018 Feb; 43():48-53. PubMed ID: 28843664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.